A structure-function approach to optimizing TLR4 ligands for human vaccines

Adjuvants are combined with vaccine antigens to enhance and modify immune responses, and have historically been primarily crude, undefined entities. Introducing toll-like receptor (TLR) ligands has led to a new generation of adjuvants, with TLR4 ligands being the most extensively used in human vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Darrick, Fox, Christopher B, Day, Tracey A, Guderian, Jeffrey A, Liang, Hong, Rolf, Tom, Vergara, Julie, Sagawa, Zachary K, Ireton, Greg, Orr, Mark T, Desbien, Anthony, Duthie, Malcolm S, Coler, Rhea N, Reed, Steven G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133366/
https://www.ncbi.nlm.nih.gov/pubmed/27990284
http://dx.doi.org/10.1038/cti.2016.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133366/
https://www.ncbi.nlm.nih.gov/pubmed/27990284
http://dx.doi.org/10.1038/cti.2016.63

Ejemplares similares